Amino acid metabolic reprogramming in clear cell renal cell carcinoma: Pathogenic mechanisms and therapeutic targeting

This publication has 137 references indexed in Scilit:

• The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS1
  Molecular Carcinogenesis, 2024
• Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma
  JAMA Oncology, 2022
• The multiple roles and therapeutic potential of HSP60 in cancer
  Biochemical Pharmacology, 2022
• Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target
  Amino Acids, 2021
• Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non‐ketotic hyperglycinemia
  Journal of Inherited Metabolic Disease, 2020
• The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?
  Cancer Letters, 2020
• Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma
  Cellular and Molecular Life Sciences, 2020
• A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
  Pediatric Blood & Cancer, 2016
• Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
  Gastric Cancer, 2016
• Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivationviaarginine deiminase
  International Journal of Cancer, 2006